In the fight against Antimicrobial Resistance, bioMérieux and Specific Diagnostics announce a co-exclusive distribution agreement for the SPECIFIC REVEAL® Rapid AST system in Europe
Subscribe

29 Jun 2021 18:28 CEST

Company Name

BIOMERIEUX

ISN

FR0013280286

Market

Euronext

Symbol

BIM

See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo

16165_991879_PR__bioMrieux_and_Specific_Diagnostics_agreement__20210629.pdf

Source

BIOMERIEUX

Provider

Les Echos

Attachments

  • Original document
  • Permalink

Disclaimer

BioMérieux SA published this content on 29 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2021 17:40:05 UTC.